American International Journal of
Research in Science, Technology,
Engineering & Mathematics
Available online at http://www.iasir.net
ISSN (Print): 2328-3491, ISSN (Online): 2328-3580, ISSN (CD-ROM): 2328-3629
AIJRSTEM is a refereed, indexed, peer-reviewed, multidisciplinary and open access journal published by
I. Association of Scientific Innovation and Research (IASIR), USA
International
(An Association Unifying the Sciences, Engineering, and Applied Research)
SYNTHESIS AND CHARACTERIZATION OF ZINC OXIDE
NANOPARTICLES USING Curcuma amada AND IT’S IN VITRO ANTIDIABETIC ACTIVITY
1*
G. SUBHA1, M. KALAISELVI1*
Department of Biochemistry (PG), Kongunadu Arts and Science College,
Coimbatore-29, Tamil Nadu, India
mksbiochem2018@gmail.com
*Corresponding author:
Abstract: The synthesis of nanoparticles is an expanding research area due to the potential applications in
the development of novel technologies. Particularly, naturally blended nanomaterial has turned into a vital
part of nanotechnology. The present work, described the synthesis of Zinc oxide nanoparticles (ZnO NPs)
using rhizomes aqueous extract of C. amada its anti diabetic activities. The obtained nanoparticle was
characterized by UV- visible spectroscopy, Fourier transform infrared spectroscopy (FTIR), SEM, EDX
analysis. In this study we also investigated anti diabetic activity of green synthesized ZnO NPs. The results
depicted concentration of ZnO NPs was increased (100, 500 μg/ml) and also increase in anti diabetic
activities α-amylase and α-glucosidase inhibitors effective. The alpha amylase inhibition assay showed
that340μg/ml, 350μg/ml respectively. The α-glucosidase inhibition IC50 was 300μg/ml, 340μg/ml respectively.
However, green synthesized ZnO NPs was more potent than ZnO NPs and rhizomes aqueous extract of C.
amada. The results of the work therefore clearly indicate the potential of those extracts to manage
hyperglycemia.
Keywords: ZnO NPs, Green synthesis, FT-IR, Anti diabetic, α- amylase, α-glucosidase
I. INTRODUCTION
Diabetes mellitus (DM) refers to a group of common metabolic disorders that share the phenotype of
hyperglycaemia with disturbance of carbohydrate, fat and protein metabolism resulting from imperfections in
insulin secretion, insulin action or both. Frequent distinct types of DM are begun by a complex interaction of
genetics and environmental factors. Depending on the ethology of the DM, factors contributing to
hyperglycaemia include reduced insulin secretion, decreased glucose utilization and increased glucose
production [1]. According to Indian Council of Medical Research India Diabetes Study (ICMR-INDIAB study)
showed that India had fastest growing disease:72 million people with diabetes in 2017 figure expected to nearly
double 134 million by 2025 by [2] .
The application of nanotechnology to medicine is called Nano medicine. Research and technology development
at the atomic, molecular and macromolecular levels in the length scale of approximately 1-100 nanometre range,
to provide a fundamental understanding of phenomena and materials at the nanoscale and to create and use
structures, devices and systems that have novel properties and functions because of their small and/or
intermediate size [3]. These applications take advantage of the unique properties of nanoparticles as drugs or
constituents of drugs or are designed for new strategies to controlled release, drug targeting, and salvage of
drugs with low bioavailability. Hopefully, the new kind of treatment may help in making the everyday lives of
millions of diabetes patients more tolerable [4].
Mammalian α-amylase is a prominent enzyme in the pancreatic juice which breaks down large and insoluble
starch molecules into absorbable molecules ultimately maltose [5]. α-glucosidase, on the other hand, anchored
in the mucosal brush border of the small intestine catalyzes the end step of digestion of starch and disaccharides
that are abundant in human diet [6]. Inhibitors of α-amylase and α-glucosidase delay the breakdown of
carbohydrate in the small intestine and decrease the postprandial blood glucose excursion levels in diabetic
patients. The inhibition of these two prominent enzymes has been found as a useful and effective strategy to
lower the levels of postprandial hyperglycemia [7]. They serve as the major digestive enzymes and help in
intestinal absorption. Alpha amylase and glucosidase inhibitors are the potential targets in the development of
lead compounds for the treatment of diabetes [8].
Extensive research has been carried out to screen the bioactivity of these inhibitors because of their significant
importance in health care and medicine. Plant food rich in polyphenols have been reported to cause effects
AIJRSTEM 19-230; © 2019, AIJRSTEM All Rights Reserved
Page 149
Kalaiselvi et al.., American International Journal of Research in Science, Technology, Engineering & Mathematics,26(1), March-May
2019, pp. 149-156
similar to insulin in the utilization of glucose and act as good inhibitors of key enzymes like alpha amylase and
alpha glucosidase associated with type 2 diabetes. Studies have also shown that bioactivity of polyphenols in
plants is linked to their antioxidant activity and many of these plants also possess hypoglycaemic properties [9].
Traditional Indian have long used of plant and herbal extracts as an anti-diabetic agents [10]. Therefore,
exploration on traditional medicinal plants has become more important and researches are challenging to find
the new effective and safe therapeutic agent for the treatment of diabetes. The Indian herb C. amada commonly
called as Mango ginger exhibited significant resistance to both the pathogens is an important medicinal plant
belongs to the family Zingiberaceae. The major constituent found in rhizomes is curcuminoids, penolic
compounds, terpinoids and essential oil. The mango ginger has the numerous biological activities such as
antioxidant, antibacterial, anti-inflammatory, antiallergic, antifungal, platelet aggregation inhibition activity and
analgesic activity [11].
However, the inhibitory effect of C. amada on α-amylase and α-glucosidase enzymes has not yet been reported.
Hence, the present study was aimed to investigate the in vitro anti-diabetic activity of C. amada aqueous extract
and ZnO NPs on α-amylase and α-glucosidase enzymes.
II. MATERIALS AND METHODS
2.1 Preparation of hot water extraction
The collected rhizome sample was washed, shade dried and powdered. 50 g of dried powder of C. amada
rhizome was extracted in 500 ml of distilled water. The resultant rhizomes extract was concentrated to dryness
and used for further studies.
2.2 Synthesis of ZnO NPs using C. amada
5 g of dried aqueous extract was dissolved in 50 ml of distilled water. From that 20 ml of extract was taken and
heated at 50ºC for 10 min and 50 ml of 91 mM of zinc acetate solution (1 g of zinc acetate was dissolved in 50
ml of distilled water) was added drop wise under stirring condition. The reaction mixture became white and
cream coloured precipitate of zinc hydroxide was formed. The content was left over for 30 min for complete
reduction to zinc hydroxide. Then the precipitate was collected by centrifugation at 16,000 rpm for 10 min at
4ºC [12].
Green Synthesis of Zinc Oxide Nanoparticles
0.91 mM Zinc acetate
dihydrate (Zn(O2CCH3)2
50ml Curcuma amada
rhizomes extract
Stirred for 15 minutes
at 600 temperature
was added
drop-wise
pH12
After 20 min to
add sample
NaOH
Magnetic stirrer for
2 hrs.
Filtration
Drying at 80 C
Gnanasangeetha and Thambavani 2013
2.3 Characterization of ZnO NPs using C. amada
The bio reduction of ZnO NPs was monitored using UV–Visible spectroscopy, Fourier transform infrared (FTIR) spectroscopy, particle size analysis, Scanning electron microscope (SEM) and, EDAX analysis to determine
the functional groups present, average particle size and morphology of the ZnO NPs.
2.4 In vitro anti-diabetic activity of aqueous extract and ZnO NPs from C. amada
2.4.1 Determination of α-amylase inhibitory activity
100 -500 µg/ml of different concentrations of the C. amada aqueous extract and ZnO NPs were allowed to react
with 100 µl of the α-amylase enzyme and 100 µl of 2 mM phosphate buffer (pH 6.9). After 20 min of
incubation, 100 µL of 1% starch solution was added. The same was performed for the control where 200 µl of
the enzyme was replaced by the buffer. After incubation for 5 min, 500 µl of dinitro salicylic acid reagent was
added to both control and test, and were boiled for 5 min in a water bath. The absorbance was recorded at 540
AIJRSTEM 19-230; © 2019, AIJRSTEM All Rights Reserved
Page 150
Kalaiselvi et al.., American International Journal of Research in Science, Technology, Engineering & Mathematics,26(1), March-May
2019, pp. 149-156
nm, and the result was interpreted regarding the IC50 values (effective concentration showing 50% inhibition
activity) [13]. The percentage inhibition was calculated according to the formula:
Inhibition (%) = Abs 540 (control) – Abs 540 (extract) × 100
Abs 540 (control)
The IC50 values were resolute from plots of percent inhibition against log inhibitor concentration and were
calculated by non linear deterioration analysis from the mean inhibitory values. Acarbose was used as the
reference alpha-amylase inhibitor. All the tests were performed in triplicates.
2.4.2 Determination of α-glucosidase inhibitory activity
100-500 µg/ml of different concentrations of the C. amada aqueous extract and ZnO NPs were allowed to react
with 100 µl of the α-glucosidase enzyme and 100 µl of 2 mM phosphate buffer (pH 6.9). After 20 min of
incubation, 100 µL of 5 mM p-nitrophenyl α-D-glucopyranoside solution was added. The same was performed
for the control where 200 µl of the enzyme was replaced by the buffer. After incubation for 5 min, 1000 μL
Na2CO3 50 mM was added to both control and test, and were boiled for 5 min in a water bath. The absorbance
was recorded at 410 nm, and the result was interpreted regarding the IC 50 values (effective concentration
showing 50% inhibition activity) [14]. The percentage inhibition was calculated according to the formula.
Inhibition (%) = Abs 410 (control) – Abs 410 (extract) × 100
Abs 410 (control)
The IC50 values were resolute from plots of percent inhibition against log inhibitor concentration and were
calculated by non linear deterioration analysis from the mean inhibitory values. Acarbose was used as the
reference alpha glucosidase inhibitor. All the tests were performed in triplicates.
III. RESULTS AND DISCUSSION
3.1 Synthesis of ZnO NPs from C. amada aqueous extract
Using green synthesis, reduction of metal salts into metal nanoparticles is always accompanied by the colour
change of reaction medium. In the present study, the colourless zinc acetate solution is changed after drop wise
addition of C. amada extract at zero second. After 2 hrs, a pale white precipitate was obtained indicates the
formation of ZnO NPs which was dried it in hot air oven (Figure 1).
Zinc acetate soluction
Zinc acetate +C.amada after
(0 sec incubation)
(After 2 hours)
Figure 1. ZnO NPs synthesis
3.2 UV–visible spectroscopy
UV–Visible absorption spectra of the ZnO particles synthesized from the mixture were shown in Figure 2. The
optical properties of nanoparticle were determined using UV-Vis 2202+ Double Beam spectrophotometer. The
biological synthesis of ZnO NPs is focusing on controlled the absorption peak was obtained at 290-350 nm
wavelengths. It is generally recognized that UV–Vis spectra could be used to examine the size and shape
controlled nanoparticles in aqueous suspension [15] the samples exhibit strong UV absorption spectra with the
absorption peak ranging from 220 nm and 250 nm due to ZnONPS was stored in dried form in centrifuge tubes
and was found to be stable after 4 months of room temperature storage.
Arulmozhi et al. [16]revealed a green methodology for the combination of zinc oxide nanoparticles (ZnO NPs)
utilizing watery concentrate of Atalantia monophylla by estimating absorbance at its qualities estimation of to be
at 352 and 410 nm separately. In S. grandiflora blend of ZnO NPs shown UV-unmistakable assimilation tops at
235 nm which was accounted for by [17].
AIJRSTEM 19-230; © 2019, AIJRSTEM All Rights Reserved
Page 151
Kalaiselvi et al.., American International Journal of Research in Science, Technology, Engineering & Mathematics,26(1), March-May
2019, pp. 149-156
Figure 2: UV-VIS spectrum analysis of ZnO NPs
3.3 FT-IR spectroscopy
FT-IR spectral analysis for characteristic functional groups present in ZnONPs was shown in Figure 3. The
spectrum obtained for synthesis clearly shows ZnO absorption band near 4000-500 cm1. The peak at 3454
pinnacle spoken to O-H gather extending of O-H, H-fortified single scaffold. The peaks somewhere in the range
of 3340.6 and 3258.2 compare to H fortified OH stretch and N=H extend. The 1377 pinnacle results from
fragrant amines and the two tops at 1040 and 1026.8 outcome from C=N stretch of aliphatic amines. The 943
and 617 pinnacles compare to alkanes and as far as anyone knows, C=H twisting in alkynes, separately.
Trademark practical gatherings in charge of development of the particles in the examples were recorded.
Figure 3: FTIR analysis of ZnO NPs
3.4 Scanning Electron Microscopy (SEM) Analysis
The morphology of the prepared nanoparticles was examined using scanning electron microscopy (SEM).
Figure 4 show the surface morphology of ZnO NPs using C. amada aqueous extract under different
magnifications. SEM image showed ZnO NPs were homogenous and symmetrical in the shape.
AIJRSTEM 19-230; © 2019, AIJRSTEM All Rights Reserved
Page 152
Kalaiselvi et al.., American International Journal of Research in Science, Technology, Engineering & Mathematics,26(1), March-May
2019, pp. 149-156
Figure 4: SEM Synthesis of ZnO NPs
3.5 Energy Dispersive X-Ray Diffractive (EDX) analysis
The Energy Dispersive X-ray Diffractive (EDX) study was carried out for the synthesized ZnO NPs to know
about the elemental composition. EDX confirms the presence of zinc and oxygen signals of zinc oxide
nanoparticle as shown in Figure 5 and this analysis showed the peaks that corresponded to the optical absorption
of the produced nanoparticle. The elemental analysis of the nanoparticle yielded 42.73% of zinc and 57.27% of
oxygen which proves that the produced nanoparticle is in its highest purified form.
AIJRSTEM 19-230; © 2019, AIJRSTEM All Rights Reserved
Page 153
Kalaiselvi et al.., American International Journal of Research in Science, Technology, Engineering & Mathematics,26(1), March-May
2019, pp. 149-156
Element
Line
OK
Zn K
Zn L
Total
Weight %
Weight %
Error
± 1.26
± 7.42
---
Atom %
24.70
57.27
75.30
42.73
----100.00
100.00
Figure 5: EDX spectrum of synthesized zinc oxide nanoparticles
ZnO-NPs have been reported to zinc and oxygen was found to be 76.32 and 23.68, ZnONPs using Ocimum
basilicum leaves extract 18].
3.6 In vitro anti-diabetic activity
3.6.1 α-amylase inhibitory activity
Alpha-amylases are digestive enzymes which hydrolyze glycosidic bonds in starch to glucose, maltose. With the
advent of new frontiers in biotechnology, the spectrum of amylase application has expanded into many other
fields, such as clinical, medicinal and analytical chemistry [19].
The in vitro α-amylase inhibitory activity of aqueous extract and ZnO NPs from C. amada was tested. The result
of α-amylase inhibitory activity of C. amada aqueous extract and ZnO NPs was shown in Figure 6. The
percentage inhibition of aqueous extract, ZnO NPs and standard acarbose was found to 71 %, 74 % and 88.2%
at a maximum concentration 500 μg/mL respectively with its IC50 value of was found to be 340μg/ml and
350μg/ml mL compared to reference acarbose 290μg/ml respectively. Hence from the above results, it is clearly
indicates that ZnO NPs showed maximum inhibition when compared to that of aqueous extract of C. amada
which shows ZnO NPs have a better antidiabetic activity.
Figure 6: α-amylase inhibitory activity
AIJRSTEM 19-230; © 2019, AIJRSTEM All Rights Reserved
Page 154
Kalaiselvi et al.., American International Journal of Research in Science, Technology, Engineering & Mathematics,26(1), March-May
2019, pp. 149-156
Previous studies concerning other plants were screened for α-amylase activity and showed inhibitory activity.
They been reported that α-amylase inhibitory activity of M. lucida aqueous extract showed IC50 value of
2.30mg/mL were reported by [7]. Laoufi et al reported that O. angustissima have more potent inhibitor of αamylase showed at 77% at a concentration of 3.3 mg/mL respectively. Our studies was also coincidence with the
previous report of α-amylase inhibitory activity of G. officinalis, P. vulgaris and T. indica obtained 35, 45-75,
90% inhibition of α-amylase at concentration of 200 mg/mL [21].
3.6.2 α-glucosidase inhibitory activity
The result of α-glucosidase inhibitors activity of C. amada aqueous extract and ZnO NPs was shown in Figure
7. The percentage inhibition of aqueous extract, ZnO NPs and standard acarbose was found to 77 %, 72 % and
94% at a maximum concentration 500 μg/mL respectively with its IC50 value of was found to be 300μg/ml and
340μg/ml mL compared to reference acarbose 270μg/ml respectively. Hence from the above results, it is clearly
indicates that ZnO NPs showed maximum inhibition when compared to that of aqueous extract of C. amada
which shows ZnO NPs have a better antidiabetic activity.
Figure 7: α- Glucosidase inhibitory activity
Previous studies concerning other plants were screened for α-glucosidase activity and showed inhibitory
activity. Nair et al., reported that methanolic extracts of A. heterophyllus, A. altilis, P. betel and C. zeylanicum
showed IC50 value of 129.85, 76.90, 140.01 and 96.56 μg/ml respectively. Kazeem et al. reported that P. nitida
have more potentials inhibitor of acetone extract of were IC50 value of 3.00 mg/ml respectively. They been
reported that α- glucosidase inhibitory activity of T. fragosa extracts showed 55% inhibition of the activity were
reported by [22]. From the above results, it can be concluded that C. amada water extracts and ZnONPs can be
excellent choice of drug with α-glucosidase inhibitory activity and can thus reduce the rate of digestion and
absorption of postprandial hyperglycemia.
IV. CONCLUSION
The synthesis of ZnO NPs was characterized using UV–Vis, FTIR, SEM, EDX investigation. Anti-diabetic
studies results proved that the synthesized ZnO NPs and C. amada extract can be showed the maximum alpha
amylase and alpha glucosidase inhibitory activity. Biosynthesized ZnO NPs prepared from C. amada extracts
are expected to have significant applications in pharmaceutical and biomedical fields such as drug delivery more
research is required for developing a potential and valuable anti diabetic therapy using alpha amylase and alpha
glucosidase inhibitors of plant origin. In conclusion, the synthesis of ZnONPs using C. amada aqueous extract
were biosynthesis through green approach, pollution-free and eco-friendly approach for anti-diabetic activity.
V. CONFLICT OF INTEREST
We, the authors declare that they have no conflict of interests.
VI. ACKNOWLEDGEMENTS
We acknowledge our sincere thanks to our management of Kongunadu arts and Science College, Coimbatore
for providing all the facilities to carry out this work.
VII. REFERENCES
1.
2.
Arun Chaudhury , Chitharanjan Duvoor , Vijaya Sena Reddy Dendi , Shashank Kraleti , 2017; Clinical Review of Antidiabetic
Drugs: Implications for Type 2 Diabetes Mellitus Management; Frontiers in Endocrinology ; 10.3389/fendo.2017.00006
Ranjit Mohan Anjana, Mohan Deepa, et al For The ICMR–INDIAB Collaborative Study Group 2017; Prevalence of diabetes and
prediabetes in 15 states of India:results from the ICMR–INDIAB population-based cross-sectional study; Articles.
AIJRSTEM 19-230; © 2019, AIJRSTEM All Rights Reserved
Page 155
Kalaiselvi et al.., American International Journal of Research in Science, Technology, Engineering & Mathematics,26(1), March-May
2019, pp. 149-156
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
Neil Gordon , Uri Sagman . Nanomedicine Taxonomy; Canadian NanoBusiness Alliance 1-28(2017)
Arya A K, Lalit Kumar, Deepa Pokharia, Kamlakar Tripathi 2017;Applications Of Nanotechnology In Diabetes Digest Journal of
Nanomaterials and Biostructures Vol. 3, No.4, , p. 221 – 225.
Gupta R, Gigras P, Mohapatra H, Goswami,VK, Chauhan B. Microbial α-amylases: a biotechnological perspective, Process
Biochem 2003; 38: 1599- 1616.
Anam K, Widharna RM, Kusrini D. Alpha-glucosidase inhibitor of Terminalia species. Int J Pharmacol 2009; 5: 277-280.
Kazeem M. I, Adamson .J. O and Ogunwande .I.A.2013; Modes of Inhibition of 𝛼-Amylase and 𝛼-Glucosidase By Aqueous
Extract Of Morinda Lucida Benth Leaf; Biomed Research International; ID 527570,
Subramanian Rammohan, Zaini Asmawi M. and Amirin Sadikun;(2008) In vitro α-glucosidase and α-amylase enzyme inhibitory
effects of Andrographis paniculata extract and andrographolide Vol. 55 No. 2/2008, 391–398 on-line at: www.actabp.pl
Sindhu. S. Nair, Vaibhavi Kavrekar and Anshu Mishra2013; In vitro studies on alpha amylase and alpha glucosidase inhibitory
activities of selected plant extracts; European Journal of Experimental Biology, 3(1):128-132.
Katekhaye SD, Nagmoti DM. α-Glucosidase and α-amylase inhibitory activities of Pithecellobiumdulce bark and
leaves.Phytopharmacol 2013;4(1):123-30.
Samant R.L 2012;Curcuma amada Roxb.: A Phytopharmacological Review; Journal of Pharmacy Research,5(4),1992-1993.
Gnanasangeetha, D., Thambavani, D.S., 2013. Biogenic production of zinc oxide nanoparticle using Acalypha indica. J. Chem.
Biol. Phys.Sci. 4 (1), 238–246.
Dhivya .G and Rajasimman .M 2015; Synthesis of silver nanoparticles using Momordica charantia and its applications ; Journal
of Chemical and Pharmaceutical Research, 7(9):107-113.
Jung M, Park M, Chul H.L, Kang Y, Seok-Kang E, Ki-Kim S, Curr. Med. Chem, 2006, 13,1
Gunalan Sangeetha , Sivaraj Rajeshwari, , Rajendran Venckatesh(2011); Green synthesis of zinc oxide nanoparticles by aloe
barbadensis miller leaf extract: Structure and optical properties Materials Research Bulletin 46 2560–2566
Arulmozhi P., Sriram .S,Praseetha P.K. ,Vijayakumar .S(2018); Green synthesis of zinc oxide nanoparticles using Atalantia
monophylla leaf
extracts:
Characterization
andantimicrobialanalysis;MaterialsScienceinSemiconductorProcessingwww.sciencedirect.com/science/journal/13698001
Prema .S .R and Kandasamy Sengodan(2017) Synthesis and Characterization of Zinc Oxide and Iron Oxide Nanoparticles Using
Sesbania grandiflora Leaf Extract as Reducing Agent ;Journal of Nanoscience ID 8348507.
Mohsen Mobini-Dehkordi and Fahime Afzal Javan (2012);Application of alpha-amylase in biotechnology;Journal of Biology
and today's world pages: 39-50.
Kazeem.M, Jesuyon .V Ogunbiyi and Anofi OT Ashafa 2013; In vitro Studies on the Inhibition of α-Amylase and α-Glucosidase
by Leaf Extracts of Picralima nitida (Stapf); ISSN: 1596-5996
Laoufi H, Benariba N, Adjdir S, Djaziri R. In vitro α-amylase and α-glucosidase inhibitory activity of Ononis angustissima
extracts. J App Pharm Sci, 2017; 7 (02): 191-198
Sales PM, Souza PM, Simioni LA, Magalhães PDO, Damaris S. α-amylase Inhibitors: A review of raw material and isolated
compounds from plant source. J Pharm Pharmaceut Sci, 2012; 15(1)142-183.
Shai L.J., Masoko . P, Mokgotho M.P, Magano S.R, Mogale A.M, Boaduo N., Eloff J.N 2010;Yeast alpha glucosidase
inhibitory and antioxidant activities of six medicinal plants collected in Phalaborwa, South African Journal of Botany 465–470.
AIJRSTEM 19-230; © 2019, AIJRSTEM All Rights Reserved
Page 156